what the NHS should be funding?
Chronically embedded in the tension between Royal patronage and scientific reasoning, the UK debate about complementary and alternative medicine (CAM) is heating up. Currently the Academy of Medical Sciences is developing a 'CAM policy paper ' 
THE CRITERIA
If the NHS's commitment to evidencebased medicine is serious the criteria for NHS funding are clear. Firstly a treatment should be demonstrably effective. Secondly it should be reasonably safe. Thirdly it should be affordable. Fourthly it should compare favourably in the aforementioned domains with other therapeutic options. 4 But this is merely theory; in practice, things can turn out to be a little more complex.
RISK-BENEFIT
My team and I have extensively reviewed the effectiveness and safety of CAM. 5, 6 The intuitive assumption of enthusiasts that CAM is value for money turns out to be pure wishful thinking. 10 Interventions that involve a prolonged series of treatments at £50-100 each are clearly not cheap. A recent undercover investigation showed that the average cost for a cancer patient seeking treatment from six different London-based CAM practitioners amounted to £6107 per therapist.
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COMPARISON WITH CONVENTIONAL OPTIONS
Finally, we have to ask how the risk-benefit profiles of the CAM options in Table 1 compare to conventional treatments. This is where things change from complicated to nebulous. There is little else than conjecture to reply on; comparative studies of high quality are not available. 
14
CONCLUSION
The evidence summarised in Table 1 and in more detail elsewhere 5, 6 gives valuable pointers as to where future systematic evaluations (by NICE or other institutions) might reasonably focus. It also reveals where further primary research is likely to be most fruitful. For clinicians, it provides a practical guide as to which treatments they might want to recommend to their patients who are often all too keen to learn more about CAM. However, most of all this remains woefully tentative -the only certainty in CAM, it seems, is that uncertainty abounds.
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